Prosecution Insights
Prosecution Insights
51 pending office actions • 28 art units • 47 examiners • 0 of 51 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 25 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 25 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 11 (22%) |
| §103 only | 11 (22%) |
| §112 only | 5 (10%) |
| Double-patenting only | 2 (4%) |
| Double-patenting + other | 7 (14%) |
| Multi-statute (no §101) | 14 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEITH, NANCY J | 2 | 74.7% | +43.8% |
| DAUNER, JOSEPH G | 2 | 56.8% | +35.6% |
| KIM, TAEYOON | 2 | 51.6% | +51.8% |
| WHITEMAN, BRIAN A | 2 | 68.4% | +16.7% |
| TRAN, CHRISTINA L | 1 | 48.2% | +45.5% |
| HEIN, DEVIN C | 1 | 46.0% | +29.8% |
| ZHONG, WAYNESHAOBIN | 1 | 72.5% | +21.3% |
| HOLLOMAN, NANNETTE | 1 | 60.5% | +23.1% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 58.6% | +39.6% |
| YU, MISOOK | 1 | 38.9% | +17.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19288411 | MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY | SKIBINSKY, ANNA | 50d overdue |
| 17756211 | Protein Structure Prediction | AUGER, NOAH ANDREW | 36d overdue |
| 18011832 | ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME | SCHACHERMEYER, SAMANTHA LYNN | 31d overdue |
| 17433658 | COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES | KIM, TAEYOON | 29d overdue |
| 18945759 | SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT | PAULS, JOHN A | 23d overdue |
| 18444227 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | DAUNER, JOSEPH G | 2d overdue |
| 18154618 | COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF | LIU, TRACY | 5d |
| 17929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEE, JAE W | 6d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19272711 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEITH, NANCY J | 89d overdue |
| 19272775 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEITH, NANCY J | 86d overdue |
| 17433658 | COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES | KIM, TAEYOON | 29d overdue |
| 18444227 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | DAUNER, JOSEPH G | 2d overdue |
| 17795943 | DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES | WHITEMAN, BRIAN A | 6d |
| 18038630 | ADIPOGENIC CELL COMPOSITIONS AND METHODS | KIM, TAEYOON | 13d |
| 18362410 | IMMUNOMODULATORY PROTEINS AND RELATED METHODS | YU, MISOOK | 21d |
| 18474060 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | DAUNER, JOSEPH G | 70d |
| Art Unit | Apps |
|---|---|
| 1636 | 7 |
| 1635 | 5 |
| 1631 | 4 |
| 1637 | 3 |
| 1682 | 3 |
| 1671 | 2 |
| 1656 | 2 |
| 1638 | 2 |
| 1634 | 2 |
| 3686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19535829 | DNA COMPOSITIONS AND RELATED METHODS | TRAN, CHRISTINA L | 1637 | §103DP | Non-Final OA | — | Pending | Feb 10, 2026 |
| 18889904 | SYSTEMS AND METHODS FOR DESIGNING AND CONDUCTING CLINICAL TRIALS AND BIOMARKER VALIDATION STUDIES | HEIN, DEVIN C | 3686 | §101§102§103 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18730112 | POLYNUCLEOTIDES FOR MODIFYING ORGANISMS | ZHONG, WAYNESHAOBIN | 1662 | §103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18440188 | CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS | HOLLOMAN, NANNETTE | 1612 | §102§103 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18283242 | PRODUCTION OF CIRCULAR POLYRIBONUCLEOTIDES IN A EUKARYOTIC SYSTEM | SULLIVAN, STEPHANIE LAUREN | 1635 | DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18362410 | IMMUNOMODULATORY PROTEINS AND RELATED METHODS | YU, MISOOK | 1641 | DP | Final Rejection | 21d | Pending | Jul 31, 2023 |
| 19303663 | METHODS AND COMPOSITIONS FOR THE MODIFICATION OF PLANTS | KEOGH, MATTHEW R | 1663 | §103§112 | Non-Final OA | — | Pending | Aug 19, 2025 |
| 19288411 | MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY | SKIBINSKY, ANNA | 1635 | §101§103 | Non-Final OA | 50d overdue | Pending | Aug 01, 2025 |
| 19287202 | MULTIPLE-TIERED SCREENING AND DIAGNOSTIC ANALYSIS | LIN, JERRY | 1685 | §101§102§112 | Non-Final OA | — | Pending | Jul 31, 2025 |
| 19272775 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEITH, NANCY J | 1636 | §103Other | Final Rejection | 86d overdue | Pending | Jul 17, 2025 |
| 19272711 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEITH, NANCY J | 1636 | §103Other | Final Rejection | 89d overdue | Pending | Jul 17, 2025 |
| 18945759 | SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT | PAULS, JOHN A | 3683 | §101§103§112Other | Final Rejection | 23d overdue | Pending | Nov 13, 2024 |
| 18712809 | IMMUNOGENIC COMPOSITIONS AND THEIR USES | GILL, RACHEL B | — | §101§102§103§112DP | Non-Final OA | — | Pending | May 23, 2024 |
| 18590275 | HBB-MODULATING COMPOSITIONS AND METHODS | MEYERING, SHABANA SHABBEER | 1635 | §103Other | Final Rejection | — | Pending | Feb 28, 2024 |
| 18687661 | METHODS AND COMPOSITIONS FOR INDUCING FETAL HEMOGLOBIN, MODULATING ERYTHROID CELL LINEAGES, AND PERTURBING MEGAKARYOCYTE LINEAGES | BARRON, SEAN C | 1653 | §102§112DP | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18444227 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | DAUNER, JOSEPH G | 1682 | §103§112 | Final Rejection | 2d overdue | Pending | Feb 16, 2024 |
| 18561964 | METHODS OF ENRICHING FOR CIRCULAR POLYRIBONUCLEOTIDES | RAVINDRA, KRISHNA NUGGEHALLI | — | §112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18561922 | METHODS OF ENRICHING FOR CIRCULAR POLYRIBONUCLEOTIDES | YU, DAVID TUYANG | 1635 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18554139 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | LEONARD, ARTHUR S | 1631 | §101§102§103DP | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18474060 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | DAUNER, JOSEPH G | 1682 | §103§112DPOther | Non-Final OA | 70d | Pending | Sep 25, 2023 |
| 18282644 | LTR TRANSPOSON COMPOSITIONS AND METHODS | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18269450 | COMPOSITIONS OF MODIFIED TREMS AND USES THEREOF | YU, DELPHINUS DOU YI | 1636 | §102§103§112Other | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18038630 | ADIPOGENIC CELL COMPOSITIONS AND METHODS | KIM, TAEYOON | 1631 | §101§102§112 | Non-Final OA | 13d | Pending | May 24, 2023 |
| 18024542 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | FOLEY, SHANON A | 1671 | §103§112 | Final Rejection | 22d | Pending | Mar 03, 2023 |
| 18173049 | INTRA-INDIVIDUAL ANALYSIS FOR PRESENCE OF HEALTH CONDITIONS | TURPIN, ZACHARY MARK | 1682 | §101DP | Final Rejection | — | Pending | Feb 22, 2023 |
| 18011832 | ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §101§102§103 | Final Rejection | 31d overdue | Pending | Dec 20, 2022 |
| 18061632 | TEMPLATE GUIDE RNA MOLECULES | ZARA, JANE J | 1637 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2022 |
| 17926254 | COMPOSITIONS AND METHODS FOR PRODUCING HUMAN POLYCLONAL ANTIBODIES | OUSPENSKI, ILIA I | 1644 | §102DP | Non-Final OA | — | Pending | Nov 18, 2022 |
| 17925920 | CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES | BUCKMASTER, MARLENE VRENI | 1672 | §103 | Final Rejection | 10d overdue | Pending | Nov 17, 2022 |
| 17925966 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | HILL, MYRON G | 1671 | §103DP | Final Rejection | — | Pending | Nov 17, 2022 |
| 17914307 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | WHITEMAN, BRIAN A | 1636 | §103DPOther | Non-Final OA | — | Pending | Sep 23, 2022 |
| 17929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | LEE, JAE W | 1656 | §103§112 | Non-Final OA | 6d | Pending | Sep 01, 2022 |
| 17795939 | COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | JONES-FOSTER, ERICA NICOLE | 1656 | §103§112 | Non-Final OA | — | Pending | Jul 28, 2022 |
| 17795943 | DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES | WHITEMAN, BRIAN A | 1636 | §103Other | Final Rejection | 6d | Pending | Jul 28, 2022 |
| 17756211 | Protein Structure Prediction | AUGER, NOAH ANDREW | 1687 | §101§103§112 | Final Rejection | 36d overdue | Pending | May 19, 2022 |
| 17597844 | MACHINE LEARNING GUIDED POLYPEPTIDE DESIGN | DARRIGRAND, EMILY ANN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Jan 26, 2022 |
| 17577942 | RECOMBINASE COMPOSITIONS AND METHODS OF USE | MCLEOD, AFRICA MHAIRIE | 1635 | §112 | Final Rejection | 21d | Pending | Jan 18, 2022 |
| 17433655 | POLYRIBONUCLEOTIDES AND COSMETIC USES THEREOF | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103Other | Final Rejection | 31d overdue | Pending | Aug 25, 2021 |
| 17433658 | COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES | KIM, TAEYOON | 1631 | §102§103Other | Final Rejection | 29d overdue | Pending | Aug 25, 2021 |
| 17428356 | MACHINE LEARNING GUIDED POLYPEPTIDE ANALYSIS | PRESSLY, KURT NICHOLAS | 2125 | §101 | Final Rejection | — | Pending | Aug 04, 2021 |
| 17262591 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | ZAHORIK, AMANDA MARY | 1636 | §103§112 | Final Rejection | 7d | Pending | Jan 22, 2021 |
| 18257483 | COMPOSITIONS AND METHODS FOR MODULATING MYC EXPRESSION | COFFA, SERGIO | 1658 | §112DP | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18201882 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | LEE, WILLIAM Y | 1623 | §112 | Non-Final OA | — | Pending | May 25, 2023 |
| 18154618 | COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF | LIU, TRACY | 1614 | §103§112 | Non-Final OA | 5d | Pending | Jan 13, 2023 |
| 18010674 | METHODS OF IDENTIFYING AND CHARACTERIZING ANELLOVIRUSES AND USES THEREOF | KELLY, ROBERT M | 1638 | §112 | Final Rejection | 69d | Pending | Dec 15, 2022 |
| 18009476 | BACULOVIRUS EXPRESSION SYSTEMS | THUESON, HANNA MARIE | 1638 | §103 | Final Rejection | 114d overdue | Pending | Dec 09, 2022 |
| 17413297 | ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103Other | Final Rejection | 45d overdue | Pending | Jun 11, 2021 |
| 17293797 | FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY | SMALL, KATHERINE R | 1633 | §103 | Final Rejection | 57d | Pending | May 13, 2021 |
| 17218025 | TARGETED LIPID PARTICLES AND COMPOSITIONS AND USES THEREOF | TIWARI, VYOMA SHUBHAM | 1634 | §103 | Non-Final OA | — | Pending | Mar 30, 2021 |
| 17055077 | FUSOSOME COMPOSITIONS AND USES THEREOF | MIANO, JOSEPH PAUL | 1631 | §103Other | Final Rejection | 15d overdue | Pending | Nov 12, 2020 |
| 16970216 | COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY | RIGA, MICHAEL ANGELO | 1634 | §112 | Final Rejection | 28d overdue | Pending | Aug 14, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial